Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07399756

Mitochondrial Function After Ketamine

Sponsor: Sheba Medical Center

View on ClinicalTrials.gov

Summary

The goal of this observational study is to learn about the role of mitochondria in response to S-ketamine. in individuals with Treatment-Resistant Depression. the Research Questions are 1. Does S-ketamine treatment modulate mitochondrial function in peripheral blood cells, as reflected by mitochondrial content and circulating mitochondrial biomarkers such as GDF15? 2. Can changes in mitochondrial function serve as biomarkers for predicting or monitoring clinical response to S-ketamine treatment? Samples will be collected at baseline, 3 hours after the first treatment, and 6 weeks post-exposure, and compared between responders and non-responders

Official title: Assessment of Mitochondrial Parameters in Blood Before and After S-Ketamine Treatment

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

30

Start Date

2026-02

Completion Date

2028-01

Last Updated

2026-02-10

Healthy Volunteers

Yes

Interventions

DRUG

S (+) Ketamine

the patients are treated with S-Ketamine in order to treat there Treatment-Resistant Depression via inhalation

Locations (1)

Sheba Medical Center

Ramat Gan, Israel, Israel